GlassScriptPhysician profile
Carol A Akerman
NPI 1720039779
$5,735.07
in general payments reported to CMS, 2019-2025
25 companies · $617 in 2025
The $617 reported for 2025 was more than what 77% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $578 · 2020: $135 · 2021: $463 · 2022: $1,137 · 2023: $1,830 · 2024: $976 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,422.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,398.65 | 2019-2025 | Stravix Pl, Stravix, Grafix Pl |
| Paratek Pharmaceuticals, INC. | $619.59 | 2020-2025 | Nuzyra |
| Stryker Corporation | $589.04 | 2021-2025 | Augment Injectable, Salvation, Ortholoc 2 Lapifuse |
| Medtronic, INC. | $580.15 | 2022-2025 | Endurant Iis, Hawkone, Venaseal |
| Triad Life Sciences INC. | $568.17 | 2022 | |
| Nevro Corp. | $335.67 | 2023 | Senza |
| Horizon Therapeutics Plc | $258.59 | 2019-2023 | Krystexxa |
| Convatec INC. | $199.88 | 2023 | |
| Rikco International, LLC | $173.00 | 2019 | |
| Vaporox, INC. | $166.87 | 2023 | Vht-200 Wound Treatment System |
| Grt US Holding, INC. | $155.67 | 2022 | |
| Abbvie INC. | $143.54 | 2022-2025 | Dalvance |
| Inari Medical, INC. | $130.71 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $96.36 | 2023 | Jublia |
| Amgen INC. | $66.38 | 2024-2025 | Krystexxa |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $46.03 | 2023-2024 | Qutenza |
| Arthrosurface Incorporated | $43.81 | 2019 | |
| Depuy Synthes Sales INC. | $36.22 | 2019-2022 | |
| Baxter Healthcare | $30.88 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Integra Lifesciences Corporation | $25.68 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Osiris Therapeutics INC. | $22.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.61 | 2023 | Seglentis |
| Medtronic Vascular, INC. | $11.08 | 2020 | |
| Advanced Oxygen Therapy INC. | $10.38 | 2025 | Topical Oxygen Chamber For Extremities |
| Cashflow Solutions, LLC | $9.11 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Akerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.